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Objectives. The purpose of this Asymptomatic Cardiac Ischemia
Pilot (ACIP) data bank study was to characterize angiographic
features of coronary pathology of patients enrolled in the ACIP study.
Background. Ischemia during ambulatory electrocardiographic
(AECG) monitoring is associated with increased morbidity and
mortality. Reports relating AECG ischemia to severity or com-
plexity of coronary artery disease are few in number and small in
size and have produced conflicting results.
Methods. Coronary angiograms from patients with asymptom-
atic AECG ischemia enrolled in the ACIP study were reviewed at
a central core laboratory. Quantitative measurement of percent
stenosis and Thrombolysis in Myocardial Infarction flow grades
were used to assess the severity of coronary artery disease. Lesions
were also evaluated for the presence of intracoronary thrombus,
ulceration and lumen contour as indicators of stenosis complexity.
In addition, comparisons were made with 27 patients screened for
the ACIP study, but who were found ineligible because they did
not have AECG ischemia on 48-h Holter monitoring.
Results. A total of 329 (75%) of 439 patients with AECG
ischemia had multivessel coronary artery disease. Proximal ste-
noses >250% diameter reduction were common in patients with
AECG ischemia (62.2%), as were proximal stenoses >270%
(38.7%). Features suggesting complex plaque were found in 50.1%
of patients with AECG ischemia.
Conclusions. Multivessel coronary artery disease, severe prox-
imal stenoses and features of complex plaque were observed
frequently in patients who exhibited AECG ischemia. The pres-
ence of severe and complex coronary artery disease may explain,
in part, the increased risk for adverse outcome associated with
ischemia during activities of daily life.
(J Am Coll Cardiol 1997;29:78–84)
q1997 by the American College of Cardiology
Asymptomatic myocardial ischemic episodes detected by am-
bulatory ECG (AECG) monitoring are common events in
patients with coronary artery disease (CAD). Recent reports
have suggested a relation between asymptomatic ischemia
recorded by AECG monitoring and adverse clinical outcomes
(1–14).
Little is known about the details of the angiographic
coronary pathology of patients with AECG ischemia. Reports
relating AECG ischemia to the severity of CAD are few in
number and small in size and have produced conflicting results
(14–19). None of these studies has used central core laboratory
quantitative angiographic review.
Recent pathologic data suggest that plaque rupture and
thrombosis are common events leading not only to unstable
clinical syndromes but also to progression of CAD in asymp-
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tomatic or stable patients (20–26). It is therefore important to
investigate the relation between AECG ischemia and the
presence of complex coronary artery lesions.
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study
investigated the efficacy and safety of therapy to alleviate
ischemia, as well as the feasibility of a trial to compare the
effect of therapies on clinical events (27–30). The trial provides
a unique opportunity to examine the relation between coro-
nary angiographic pathology and AECG ischemia in a well-
characterized group of patients with stable CAD. The purpose
of this study was to characterize, both quantitatively (lesion
severity) and qualitatively (lesion complexity), the coronary
angiographic pathology of patients enrolled in ACIP and to
investigate the relation between coronary pathoanatomy and
the presence of AECG ischemia.
Methods
The design, baseline characteristics and primary outcome
data of patients in ACIP have been reported (27–30). Data are
reported here for 439 ACIP patients. As previously reported
(31), because of unacceptable performance in the conduct of
the trial at one clinical unit, it was determined that the data
from that unit were not comparable to the data from the other
clinical units. Therefore, all 60 patients from that clinical unit
have been excluded from this report. Patients were eligible for
inclusion if they met all the following criteria: one or more
episodes of asymptomatic ischemia on 48-h ambulatory ECG;
evidence of ischemia on stress testing; and revascularizable
CAD. Coronary artery disease was defined as $50% diameter
reduction of a major coronary artery or branch seen on a
coronary angiogram. For the purposes of this data bank study,
only 439 of 558 ACIP patients with angiograms performed
within 90 days of the screening AECG (in the majority of cases
within 4 weeks) were included. In almost all cases ($95%),
angiograms were performed electively in stable patients be-
cause of abnormal results of noninvasive testing. Reasons for
exclusion from the trial were myocardial infarction within 4
weeks, coronary angioplasty within 6 months, coronary artery
bypass surgery within 6 months, presence of unstable angina at
study entry, heart failure with New York Heart Association
functional class $III, significant noncardiac illness or inade-
quate control of angina on maximal medical therapy.
Coronary angiography. All coronary angiograms were re-
viewed in the central core laboratory. The cine film must have
been of adequate quality to confirm eligibility and suitability
for revascularization. Major coronary arteries were defined as
the left anterior descending, left circumflex and right coronary
arteries. Diagonal and obtuse marginal branches were consid-
ered major vessels if they supplied a large enough area of
myocardium and were suitable for bypass surgery or percuta-
neous coronary angioplasty.
Severity of coronary artery disease. All coronary lesions in
major arteries or branches were measured using an electronic
cine projector–based “crosshair’s” technique (Vanguard In-
strument Corp.). The technique is analogous to electronic
calipers built into the hood of a cine projector, thus removing
viewer parallax. This technique compares favorably with auto-
mated edge detection (32). In our laboratory, the standard
deviation of the mean difference in measured percent stenosis
between the two methods was ,8%. Percent stenosis was
measured in a view demonstrating the most severe coronary
artery narrowing. Flow was visually estimated by the method
used in the Thrombolysis in Myocardial Infarction (TIMI) trial
(33). Stenoses with flow grade 0 or 1 were not measured but
assigned a value of 100% and 99%, respectively. Interobserver
variability in classifying flow grade in the core laboratory was
low, with 85% of paired readings demonstrating complete
agreement (r 5 0.924). A random 5% of all films were
interpreted twice for quality control. Collateral channels to the
distal vessel beyond a stenosis were graded as none, partial or
complete.
Stenosis complexity. Intracoronary thrombus was graded
by a scoring system ranging from 0 to 4: grade 0 5 no throm-
bus; grade 1 5 possible thrombus where the lesion borders
were hazy with a ground glass appearance; and grades 2 to 4 5
definite thrombus defined as well-delineated discrete filling
defects of increasing size. Grade 2 thrombus represents a filling
defect with a greatest linear dimension #1⁄2 vessel diameter;
grade 3 represents .1⁄2 but ,2 vessel diameters in size; and
grade 4, $2 vessel diameters in size. Interobserver variability
with this scoring system is low, with 71% of paired readings
demonstrating complete agreement and 23% differing by 1
score (r 5 0.906). Lesion ulceration was graded from 0 to 2:
grade 0 5 no ulcer; grade 1 5 possible ulcer with eccentric
lesions with overhanging edges; and grade 2 5 definite ulcer
with a discrete outpocketing of contrast opacification. Lesion
contour was graded from 0 to 2: grade 0 5 smooth lumen
borders; grade 15 ill-defined borders; and grade 25 irregular
lumen borders. “Possible complex plaque” was considered
present in lesions with any of the following criteria: a thrombus
score$1 or an ulcer score$1 or a contour score$1. “Definite
complex plaque” was considered present in lesions with any of
the following criteria: a thrombus score $2 or an ulcer score
$1 or a contour score of 2.
Statistical methods. Characteristics of patients with
AECG ischemia were compared with a small sample of
patients screened for ACIP, but without AECG ischemia using
the chi-square test for categoric variables and the t test or
Wilcoxon rank-sum test for continuous variables. Odds ratios
for the presence of AECG ischemia, given the presence of
complex plaque, with and without adjustment for covariates,
were calculated using logistic regression analysis. Percent
Abbreviations and Acronyms
ACIP 5 Asymptomatic Cardiac Ischemia Pilot study
AECG 5 ambulatory electrocardiographic
CAD 5 coronary artery disease
TIMI 5 Thrombolysis in Myocardial Infarction
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diameter stenosis in lesions with and without complex plaque
was compared using the generalized estimating equations
method to account for correlation among lesions within the
same patient (34). To account for multiple comparisons in
analyses, the ACIP protocol specified that p , 0.01 be
considered as providing some evidence for the presence of
differences, and p , 0.001 be considered as strong evidence.
Results
Patient group. A total of 1,820 patients were screened for
ACIP, 910 of whom had AECG ischemia, including 815 with at
least one asymptomatic episode. From this group with asymp-
tomatic AECG ischemia, 558 with a positive stress test and
angiographically documented CAD amenable to revasculariza-
tion were enrolled in ACIP (27–29). Thirty-three of the 558
patients had either prior coronary artery bypass graft surgery
(n 5 31) or an angiogram inadequate for analysis (n 5 2) and
were excluded from this study. An additional 86 patients
underwent coronary angiography .90 days before their qual-
ifying AECG visit and were also excluded. The remaining 439
ACIP patients comprise a group of patients with asymptomatic
AECG ischemia included in this report. Among the 910
patients screened who did not have AECG ischemia, coronary
angiograms were also reviewed in a second group of 40
patients with an abnormal exercise test, documented CAD and
no prior coronary artery bypass graft surgery but no asymp-
tomatic ischemia on 48-h AECG. Thirteen patients were
excluded because more than 90 days elapsed from the coronary
angiogram to the qualifying AECG. The remaining 27 ACIP-
screened patients comprise a comparison group without symp-
tomatic or asymptomatic AECG ischemia included in this
report. This comparison group represents screened patients for
whom angiograms could be obtained centrally and was not
chosen by random sampling. Detailed clinical history data are
not available for the 27 patients in this comparison group.
Clinical characteristics. Baseline characteristics for the
group of patients with AECG ischemia are listed in Table 1.
The mean age was 61.3 years, and the majority of patients were
men. Over half the patients had angina in the 6 weeks before
AECG screening. The patients had an average of 2.5 6 2.8
ischemic episodes per 24 h and 21.46 29.5 min of ischemia per
24 h.
Disease severity. Disease severity was characterized as the
number of vessels with stenosis $50% diameter reduction,
total number of stenoses $50% per patient, number of severe
stenoses ($95% diameter reduction) or occlusions and specif-
ically by the presence or absence of proximal stenoses in a
major artery (vs. branch). The number of vessels with stenosis
$50% is depicted in Figure 1. Approximately 75% of patients
had multivessel CAD. Distributions of number of stenoses per
patient are listed in Figure 1. The majority of patients (81.5%)
had two or more stenoses ($50% diameter reduction), and
21.2% had two or more severe stenoses ($95% diameter
reduction).
Proximal (before major side branches) stenoses $50% in
the left anterior descending, left circumflex or right coronary
arteries were found frequently in patients with AECG ischemia
(Fig. 2). Sixty-two percent of patients with AECG ischemia had
at least one proximal stenosis $50%, and 38.7% of these
patients had at least one proximal stenoses $70% diameter
reduction. The most severe stenosis was 88.1 6 14.2 (mean 6
SD).
When comparing these patients with the group of ACIP-
screened patients without AECG ischemia, the distribution of
single-, double-, and triple-vessel disease was not different (p5
0.76). Proximal stenoses $50% were found more commonly in
patients with AECG ischemia than in those without it (62.2%
vs. 37.0%, respectively, p 5 0.01), as were proximal stenoses
$70% (38.7% vs. 18.5%, respectively, p 5 0.04).
Features of complex plaque. Angiographic evidence for
definite plaque ulceration was found in at least one lesion in
10.0% of patients with AECG ischemia. Definite thrombus was
also infrequent; it was found in 3.0% of patients with AECG
ischemia. At least one lesion meeting the angiographic crite-
rion of “possible complex plaque” was found in 50.1% of
patients with AECG ischemia, whereas 34.2% of patients with
AECG ischemia had “definite complex plaque” (Fig. 3).
No patient without AECG ischemia had angiographic evi-
dence of definite plaque ulceration or thrombus, and both
possible (p 5 0.02) and definite (p 5 0.09) complex plaques
were found less frequently than in patients with AECG
ischemia (Fig. 3).
Angiographic findings in patients with and without angina
and prior myocardial infarction. Compared with patients
without angina, the number of coronary arteries with $50%
stenosis was greater among ACIP patients with angina on the
qualifying exercise treadmill test (p , 0.001) and tended to be
more common among ACIP patients reporting angina within 6
weeks of the AECG (p 5 0.04). Three-vessel disease was
present in 102 (43%) of 238 patients with and in 60 (31%) of
193 patients without angina on the exercise test and among 110
(42%) of 262 patients with versus 53 (30%) of 177 patients
without angina within 6 weeks of the AECG. The percentages




Age (yr) (mean 6 SD) 61.3 6 8.2
Gender (male) 378 (86.1)
History of diabetes 68 (15.5)
History of hypertension 168 (38.3)
History of hypercholesterolemia 189 (43.1)
History of myocardial infarction 163 (37.1)
History of angioplasty 70 (15.9)
Ever smoked 283 (64.5)
Current smoker 67 (15.5)
Angina
Within 6 wk of AECG 262 (59.7)
On exercise treadmill test 238/431 (55.2)
AECG 5 ambulatory electrocardiography.
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of patients with proximal stenoses and complex plaque were
similar among those with versus those without angina on the
exercise test or reported within 6 weeks of the AECG (all p .
0.10). The distributions of number of arteries with stenosis
$50%, presence of proximal stenosis, and presence of complex
plaque were similar among patients with versus without a
history of myocardial infarction (all p . 0.07).
Correlation of features of complex plaque with disease
severity. When combining the two groups of patients with and
without AECG ischemia (n 5 466), associations were noted
between the presence of “definite complex plaque” and several
measures of disease severity (Table 2). Of patients with
“definite complex plaque,” 45.2% had three-vessel disease
compared with 32.8% of patients without “definite complex
plaque” (p 5 0.009). In addition, 70.3% of patients with
complex plaque had three or more stenoses as opposed to only
51.8% of those without complex plaque (p, 0.001). There was
a trend for patients with complex plaque to have more
proximal stenoses ($50% and $70% diameter reductions)
than those without complex plaque (p 5 0.02 and 0.03,
respectively). The site of complex plaque, however, was not
necessarily the site of the most severe stenosis. Percent diam-
eter stenosis in lesions with and without complex plaque was
compared using the generalized estimating equations method
to account for correlation among lesions within the same
patient. The mean (6SE) difference in percent stenosis be-
tween lesions with and without “definite complex plaque” was
20.5 6 1.1 (p 5 0.67); the mean (6SE) difference between
lesions with and without “possible complex plaque” was
21.8 6 1.0 (p 5 0.07).
Logistic regression analysis was performed to examine the
relation of angiographic variables with the presence or absence
of AECG ischemia. After adjusting for the number of vessels
with $50% stenosis and the presence of proximal lesions
$50%, a trend toward an association remained between the
presence of AECG ischemia and the presence of “possible
complex plaque” (odds ratio [OR] 2.91, 99% confidence
interval [CI] 0.88 to 9.54, p 5 0.02). However, there was less
evidence for an association between AECG ischemia and the
presence of “definite complex plaque” after adjusting for
severity of disease (OR 2.26, 99% CI 0.60 to 8.56, p 5 0.11).
Among the 439 patients with AECG ischemia, the Wil-
coxon rank-sum test was performed to examine the association
between the number of ischemic episodes per 24 h and
angiographic findings. No significant association was found
between the number of ischemic episodes and the presence of
Figure 1. Number of vessels with stenosis $50% for patients with
AECG ischemia (left); percentage of patients with AECG ischemia
with 1, 2 or $3 stenoses $50% (center) and with 0, 1 or $2 severe
stenoses ($95%) (right).
Figure 2. Proximal stenosis severity. Percentage of patients with at
least one proximal stenosis$50% diameter reduction (left) and$70%
(right) for patients with AECG ischemia.
Figure 3. Presence of complex stenosis. Percentage of patients with at
least one “possible” (left) and one “definite” (right) complex plaque
for patients with (solid bars) and without AECG (crosshatched bars)
ischemia.
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possible complex plaque (p 5 0.61), definite complex plaque
(p 5 0.86), presence of proximal stenosis $50% (p 5 0.81) or
number of vessels with stenosis $50% (p 5 0.11). We noted a
trend toward more ischemic episodes per 24-h with the pres-
ence of more stenoses $50% (p 5 0.04) (Fig. 4).
There was no correlation between the severity of CAD, as
measured by the number of vessels with $50% stenosis and
12-week, 6-month or 12-month adverse outcome (ischemic
episode by AECG, hospital admission for angina, myocardial
infarction or death). In addition, the presence of possible or
definite complex plaque did not correlate with adverse out-
come. Among patients with an adverse outcome, 179 (43.3%)
of 415 had a proximal stenosis $70% versus 41 (33.6%) of 123
patients without an adverse outcome (p 5 0.06).
Discussion
This ACIP data bank study characterized angiographic
severity and complexity of CAD in patients with asymptomatic
ambulatory cardiac ischemia. The ACIP enrollment criteria,
requiring an abnormal exercise test and AECG ischemia,
identified a group of patients with critical and complex CAD.
Relation between angiographic disease severity and asymp-
tomatic cardiac ischemia. Other investigators have attempted
to measure disease severity and to correlate this with the
presence of AECG ischemia. Deedwania and Carbajal (6)
evaluated 107 patients with stable angina with AECG moni-
toring. No significant difference in severity of CAD was found.
Fifty-three percent of patients with AECG ischemia had
three-vessel CAD compared with 43% of those patients with-
out AECG ischemia. Yeung et al. (14) studied 138 patients
with stable angina. Although there was a trend toward more
patients with AECG ischemia having three-vessel CAD than
those without AECG ischemia (42% vs. 26%, respectively),
this difference was not significant. Kunkes et al. (17) studied a
heterogeneous group of 50 patients with stable angina, chest
pain after myocardial infarction and chest pain of uncertain
etiology. Those with no CAD or single-vessel CAD less
frequently had AECG ischemia than those with two- and
three-vessel disease (44% vs. 100%, respectively). Of note,
over one-third of the patients in their study had no significant
CAD (defined as $50% stenosis), yet 38% of these patients
had AECG ischemia. Common to these prior reports was a
relatively simple definition of CAD severity. When ACIP-
enrolled patients were analyzed in a central angiographic core
laboratory, severe disease was noted with 75% having multives-
sel and 58% with at least one severe stenosis ($95%) giving
rise to abnormal flow (TIMI flow grade #2). Like these other
reports, we found that when measuring severity of disease
either by total number of vessels with stenosis $50%, total
number of lesions $50% or number of stenoses $95% (in-
cluding occlusions) patients with or without AECG ischemia
were indistinguishable. The simple grading system of no,
single-, double- or triple-vessel disease is a weak predictor of
the presence of AECG ischemia.
Severe proximal stenoses were noted frequently in the
ACIP patient group with AECG ischemia. This association has
been reported previously. Mody et al. (16) found that patients
with AECG ischemia for longer than 60 min were more likely
to have proximal stenoses than patients with no AECG isch-
emia (OR 6.75, p , 0.002). This finding is in accordance with
the concept that patients with larger amounts of myocardium
jeopardized by severe proximal stenoses are expected to dem-
onstrate more readily detectable AECG ischemia.
Complex plaque was found frequently in this group with
AECG ischemia, with definite complex features noted in 34%
and possible complex features in 50% of patients. A relation
between AECG ischemia and complex coronary morphology
has been suggested by other investigators, but only in the
context of acute or unstable clinical syndromes. Bugiardini et
al. (18) studied 88 patients with unstable angina. Complex
Figure 4. Patients with AECG ischemia only: number of AECG
ischemic episodes per 24 h (y axis) for patients with 1, 2 and $3
stenoses $50% (x axis).
Table 2. Relation of Angiographic Markers of Disease Severity to






(n 5 311) p
Value[no. (%)] [no. (%)]
No. of arteries with
stenosis $50%
diameter reduction
1 31 (20.0) 86 (27.6)
2 54 (34.8) 123 (39.6) 0.009
3 70 (45.2) 102 (32.8)
No. of stenoses $50%
diameter reduction
1 17 (11.0) 69 (22.2)
2 29 (18.7) 81 (26.0) ,0.001
$3 109 (70.3) 161 (51.8)
Severity of proximal
stenosis
$50% 106 (68.4) 177 (56.9) 0.02
$70% 69 (44.5) 106 (34.1) 0.03
$95% 42 (27.1) 67 (21.5) 0.18
Maximal stenosis
(mean 6 SD)
89.7 6 13.1 87.5 6 14.7 0.32
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coronary morphology was defined visually by the presence or
absence of lesion ulceration or thrombus. Those with complex
plaque had a longer duration of AECG ischemia and a higher
likelihood of demonstrating residual AECG ischemia after
aggressive medical therapy. Pozzati et al. (19) followed 86
patients with unstable angina (some of whom may have been
included in the preceding report). Both at admission and after
3 days of medical treatment, AECG ischemia was more
frequent and more severe in patients with complex stenosis
morphology.
The significance of an association between complex plaque
and AECG ischemia found in this and other smaller studies
remains unclear. It is possible that in the ACIP study of
clinically stable patients, the presence of complex stenosis
morphology merely identified a group of patients more likely
to have severe CAD and thus more likely to have AECG
ischemia. This concept is supported by the fact that the
association between the presence of complex plaque and
AECG ischemia was dependent in part on severity of disease.
Alternatively, specific pathophysiologic events involved
with plaque rupture may give rise to AECG ischemia. Vaso-
spasm, partial or transient thrombosis or other dynamic mech-
anisms may be involved. Support for this concept is found in
recent pathologic studies, which suggest that plaque rupture
and thrombosis are the common events leading not only to
acute coronary syndromes but also to progression of CAD in
asymptomatic or stable patients (20–26). Autopsy of suicide
and accident victims reveals plaque disruption unassociated
with symptoms (24). Asymptomatic plaque disruption has been
found in ;9% of noncardiac deaths (25).
Ambulatory ECG ischemia may be a sensitive clinical
marker for atherosclerotic disease activity or progression,
which is manifested angiographically as complex plaque. As
such, AECG ischemia may reflect total ischemic burden more
accurately than angina, indicative of the presence of severe
(proximal) or progressive (complex) CAD. This would explain
the increased risk for adverse outcomes often observed in
these patients with AECG ischemia (1–14,25). Our findings of
severe and complex CAD in the majority of ACIP patients
gives some insight into the preliminary finding that 12-week
and 1-year outcomes were improved with revascularization as
compared with the two medical treatment arms; however,
whether routine coronary angiography and revascularization,
risk factor modification including lipid lowering therapy or
interventions directed at plaque stabilization such as antiplate-
let or antioxidant therapy will have an impact on clinical
outcome in patients with AECG ischemia remains unknown
and needs to be addressed in a larger clinical trial involving
symptom-versus AECG ischemia–guided therapy (29,30).
Study limitations. The study patients enrolled in ACIP had
revascularizable CAD with at least one 50% stenosis. The
comparison group of ACIP-screened patients without AECG
ischemia was small, which reduced the power to detect differ-
ences. For example, it was estimated that with alpha 5 0.01,
the power would be just under 80% to detect a 60% reduction
in prevalence among comparison group patients for a charac-
teristic that was present in half of the patients with AECG
ischemia. The comparison group was not random but was
limited to patients with a positive exercise test and an available
angiogram, which in most cases had been recently performed
for clinical purposes. The requirement for angiography may
have led the comparison group to include a higher proportion
of patients with severe disease than would be seen in a
representative sample of patients with CAD with a positive
exercise test but no ischemic episodes during AECG monitor-
ing. This bias in sampling would result in an underestimation
of average coronary morphologic differences between patients
with and without AECG ischemia. Thus, the important finding
that proximal stenoses and complex plaque were seen more
frequently in patients with AECG ischemia than in the com-
parison group will need to be confirmed through a detailed
angiographic analysis from a larger study comparing patients
with and without AECG ischemia.
Conclusions. The ACIP study is the largest and only
multicenter study characterizing coronary angiographic find-
ings in patients with AECG ischemia. The majority of patients
enrolled had severe and complex CAD. Proximal stenoses and
complex plaque were seen more frequently in patients with
AECG ischemia than in those without it. The presence of
severe and complex CAD may explain, in part, the increased
risk for an adverse outcome known to be associated with the
presence of AECG ischemia during activities of daily living.
We acknowledge Craig Pratt, MD, and Nancy L. Geller, PhD, for comments and
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manuscript.
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